|
[1]
|
Chung, M.K., Refaat, M., Shen, W., Kutyifa, V., Cha, Y., Di Biase, L., et al. (2020) Atrial Fibrillation. Journal of the American College of Cardiology, 75, 1689-1713. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Andrade, J., Khairy, P., Dobrev, D. and Nattel, S. (2014) The Clinical Profile and Pathophysiology of Atrial Fibrillation. Circulation Research, 114, 1453-1468. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Li, C., Zhang, J., Hu, W. and Li, S. (2020) Atrial Fibrosis Underlying Atrial Fibrillation (review). International Journal of Molecular Medicine, 47, Article No. 9. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Karam, B.S., Chavez-Moreno, A., Koh, W., Akar, J.G. and Akar, F.G. (2017) Oxidative Stress and Inflammation as Central Mediators of Atrial Fibrillation in Obesity and Diabetes. Cardiovascular Diabetology, 16, Article No. 120. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Dudink, E.A. (2018) The Biomarkers NT-proBNP and CA-125 Are Elevated in Patients with Idiopathic Atrial Fibrillation. Journal of Atrial Fibrillation, 11, Article 2058. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Aimo, A., Januzzi, J.L., Bayes-Genis, A., Vergaro, G., Sciarrone, P., Passino, C., et al. (2019) Clinical and Prognostic Significance of sST2 in Heart Failure. Journal of the American College of Cardiology, 74, 2193-2203. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Grabner, A., Amaral, A.P., Schramm, K., Singh, S., Sloan, A., Yanucil, C., et al. (2015) Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy. Cell Metabolism, 22, 1020-1032. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Grabner, A., Schramm, K., Silswal, N., Hendrix, M., Yanucil, C., Czaya, B., et al. (2017) FGF23/FGFR4-Mediated Left Ventricular Hypertrophy Is Reversible. Scientific Reports, 7, Article No. 1993. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Koller, L., Kleber, M.E., Brandenburg, V.M., Goliasch, G., Richter, B., Sulzgruber, P., et al. (2015) Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients with Heart Failure and Reduced Ejection Fraction. Circulation: Heart Failure, 8, 1059-1067. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Arkoumani, M., Papadopoulou-Marketou, N., Nicolaides, N.C., Kanaka-Gantenbein, C., Tentolouris, N. and Papassotiriou, I. (2019) The Clinical Impact of Growth Differentiation Factor-15 in Heart Disease: A 2019 Update. Critical Reviews in Clinical Laboratory Sciences, 57, 114-125. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Wollert, K.C. and Kempf, T. (2012) Growth Differentiation Factor 15 in Heart Failure: An Update. Current Heart Failure Reports, 9, 337-345. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Staff, A.C., Bock, A.J., Becker, C., Kempf, T., Wollert, K.C. and Davidson, B. (2010) Growth Differentiation Factor-15 as a Prognostic Biomarker in Ovarian Cancer. Gynecologic Oncology, 118, 237-243. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Wallin, U., Glimelius, B., Jirström, K., Darmanis, S., Nong, R.Y., Pontén, F., et al. (2011) Growth Differentiation Factor 15: A Prognostic Marker for Recurrence in Colorectal Cancer. British Journal of Cancer, 104, 1619-1627. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Baek, K.E., Yoon, S.R., Kim, J., Kim, K.S., Kang, S.H., Yang, Y., et al. (2009) Upregulation and Secretion of Macrophage Inhibitory Cytokine-1 (MIC-1) in Gastric Cancers. Clinica Chimica Acta, 401, 128-133. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Resl, M., Clodi, M., Vila, G., Luger, A., Neuhold, S., Wurm, R., et al. (2016) Targeted Multiple Biomarker Approach in Predicting Cardiovascular Events in Patients with Diabetes. Heart, 102, 1963-1968. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Pavo, N., Wurm, R., Neuhold, S., et al. (2016) GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes. Clinical Chemistry, 62, 1612-1620. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Tuegel, C., Katz, R., Alam, M., Bhat, Z., Bellovich, K., de Boer, I., et al. (2018) GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD. American Journal of Kidney Diseases, 72, 519-528. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
姚超永, 陈宗灿. 非瓣膜性心房颤动患者血清胆红素的变化及意义[J]. 深圳中西医结合杂志, 2017, 27(20): 152-153.
|
|
[19]
|
Vianello, E., Dozio, E., Tacchini, L., et al. (2019) ST2/IL-33 Signaling in Cardiac Fibrosis. The International Journal of Biochemistry & Cell Biology, 116, 105619. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Ye, T., Zhang, C., Wu, G., Wan, W., Liang, J., Liu, X., et al. (2019) Pinocembrin Attenuates Autonomic Dysfunction and Atrial Fibrillation Susceptibility via Inhibition of the NF-κB/TNF-α Pathway in a Rat Model of Myocardial Infarction. International Immunopharmacology, 77, Article 105926. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Matilla, L., Arrieta, V., Jover, E., Garcia-Peña, A., Martinez-Martinez, E., Sadaba, R., et al. (2020) Soluble St2 Induces Cardiac Fibroblast Activation and Collagen Synthesis via Neuropilin-1. Cells, 9, Article 1667. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
刘海洋, 刘虹. 成纤维生长因子23与慢性肾病不良预后的关系及治疗策略[J]. 中南大学学报(医学版), 2018, 43(5): 560-565.
|
|
[23]
|
Savas, O., Oktay, O., Murat, E., et al. (2016) The Relationship between FGF-23 and Ghrelin Levels in CKD Patients: Preliminary Data. The Italian Journal of Urology and Nephrology, 68, 227-232.
|
|
[24]
|
Moe, S.M., Chertow, G.M., Parfrey, P.S., Kubo, Y., Block, G.A., Correa-Rotter, R., et al. (2015) Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis. Circulation, 132, 27-39. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Olauson, H., Qureshi, A.R., Miyamoto, T., Barany, P., Heimburger, O., Lindholm, B., et al. (2010) Relation between Serum Fibroblast Growth Factor-23 Level and Mortality in Incident Dialysis Patients: Are Gender and Cardiovascular Disease Confounding the Relationship? Nephrology Dialysis Transplantation, 25, 3033-3038. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Faul, C., Amaral, A.P., Oskouei, B., Hu, M., Sloan, A., Isakova, T., et al. (2011) FGF23 Induces Left Ventricular Hypertrophy. Journal of Clinical Investigation, 121, 4393-4408. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Wischhusen, J., Melero, I. and Fridman, W.H. (2020) Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint. Frontiers in Immunology, 11, Article 951. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Heger, J., Schiegnitz, E., von Waldthausen, D., Anwar, M.M., Piper, H.M. and Euler, G. (2010) Growth Differentiation Factor 15 Acts Anti-Apoptotic and Pro-Hypertrophic in Adult Cardiomyocytes. Journal of Cellular Physiology, 224, 120-126. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Lamprea-Montealegre, J.A., Zelnick, L.R., Shlipak, M.G., Floyd, J.S., Anderson, A.H., He, J., et al. (2019) Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. Journal of the American Heart Association, 8, e012200. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
吴英乐, 程帅锋, 陈润, 等. 血清胆红素水平和房颤的关系[J]. 河南科技大学学报(医学版), 2019, 37(3): 201-204.
|
|
[31]
|
温昌霖, 张忠良, 王国华. 孤立性房颤与心脏结构功能相关性研究[J]. 实用诊断与治疗杂志, 2007, 21(6): 436-437+440.
|
|
[32]
|
Xie, E., Yu, R., Ambale-Venkatesh, B., Bakhshi, H., Heckbert, S.R., Soliman, E.Z., et al. (2020) Association of Right Atrial Structure with Incident Atrial Fibrillation: A Longitudinal Cohort Cardiovascular Magnetic Resonance Study from the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of Cardiovascular Magnetic Resonance, 22, 36. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Hasebe, H., Yoshida, K., Iida, M., Hatano, N., Muramatsu, T. and Aonuma, K. (2016) Right-to-Left Frequency Gradient during Atrial Fibrillation Initiated by Right Atrial Ectopies and Its Augmentation by Adenosine Triphosphate: Implications of Right Atrial Fibrillation. Heart Rhythm, 13, 354-363. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
富丽娟, 赵晓静, 胡微, 等. 心房颤动患者血清sST-2、apelin、NT-proBNP、炎症因子浓度与左心房内径的关系[J]. 岭南心血管病杂志, 2019, 25(5): 530-535.
|
|
[35]
|
邢文, 赵春梅, 王德国. 血清成纤维细胞生长因子23与慢性心力衰竭心室重构的相关性[J]. 临床心血管病杂志, 2016, 32(1): 36-39.
|